0001209191-20-015801.txt : 20200303
0001209191-20-015801.hdr.sgml : 20200303
20200303202729
ACCESSION NUMBER: 0001209191-20-015801
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200301
FILED AS OF DATE: 20200303
DATE AS OF CHANGE: 20200303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dispersyn Gerrit
CENTRAL INDEX KEY: 0001704417
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 20685281
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE, SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp.
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20111019
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-01
0
0001533040
Phio Pharmaceuticals Corp.
PHIO
0001704417
Dispersyn Gerrit
C/O PHIO PHARMACEUTICALS CORP.
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
0
1
0
0
President & CEO
Common stock, $0.0001 par value
2020-03-01
4
F
0
673
2.93
D
14628
D
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units.
Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55.
Caitlin Kontulis, attorney-in-fact
2020-03-03